Apex Biotechnology Corp (1733)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Apex Biotechnology Corp (1733) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011289
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and exports related products, parts and components. ApexBio’s products include glucose monitoring systems, uric acid monitoring systems, lactate monitoring system, hemoglobin monitoring system, cholesterol monitoring system, hemoglobin A1C POC system, pesticide residue quick check systems and care management and tele-health. The company operates through its manufacturing facilities in Hsinchu City and Taoyuan City in Taiwan. ApexBio is headquartered in Hsinchu, Taiwan.

Apex Biotechnology Corp (1733) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Apex Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Apex Biotechnology Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Apex Biotechnology Corp, Medical Equipment, Deal Details 10
Equity Offering 10
Apex Biotechnology Announces Public Offering Of Shares For US$6.5 Million 10
Debt Offering 11
Apex Biotech Raises USD12.8 Million in Public Offering of Bonds Due 2018 11
Acquisition 12
Apex Biotechnology Acquires 25% Stake In Omnis Health For US$10 Million 12
Apex Biotechnology Corp – Key Competitors 13
Apex Biotechnology Corp – Key Employees 14
Apex Biotechnology Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Apex Biotechnology Corp, Medical Equipment, Key Facts, 2016 2
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Apex Biotechnology Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Apex Biotechnology Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Apex Biotechnology Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Apex Biotechnology Corp, Deals By Market, 2011 to YTD 2017 8
Apex Biotechnology Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Apex Biotechnology Announces Public Offering Of Shares For US$6.5 Million 10
Apex Biotech Raises USD12.8 Million in Public Offering of Bonds Due 2018 11
Apex Biotechnology Acquires 25% Stake In Omnis Health For US$10 Million 12
Apex Biotechnology Corp, Key Competitors 13
Apex Biotechnology Corp, Key Employees 14
Apex Biotechnology Corp, Other Locations 15

★海外企業調査レポート[Apex Biotechnology Corp (1733)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Communications Limited:企業の戦略・SWOT・財務情報
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Goodrich Petroleum Corp (GDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Goodrich Petroleum Corp (Goodrich) is an independent oil and gas company. It explores, develops and produces oil and natural gas from properties that include Tuscaloosa Marine Shale in Eastern Louisiana and Southwestern Mississippi, Haynesville Shale trend in north Louisiana and east Texas, …
  • DryShips Inc.:企業のM&A・事業提携・投資動向
    DryShips Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DryShips Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Euroclear Plc
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Phibro Animal Health Corp (PAHC):企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • InfraReDx Inc-医療機器分野:企業M&A・提携分析
    Summary Infraredx Inc (Infraredx), a subsidiary of Nipro Corp is a medical device company that provides cardiovascular imaging solutions. The company offers TVC imaging system, a dual-modality intravascular imaging system that assesses plaque composition and vessel structure. Its TVC imaging system …
  • Dova Pharmaceuticals Inc (DOVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Dova Pharmaceuticals Inc (Dova), formerly PBM AKX Holdings LLC, is a clinical-stage pharmaceutical company that acquires, develops and commercializes therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (DOPTELET), a novel, oral thrombopoietin receptor a …
  • Rex International Holding Ltd (5WH):企業の財務・戦略的SWOT分析
    Summary Rex International Holding Ltd (Rex International) formerly Rex International Holding Pte Ltd is an independent exploration and production oil company. The company develops oil and gas properties across Singapore. It operates substantial oil and gas exploration concessions in the UAE, Oman, N …
  • OMEICOS Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary OMEICOS Therapeutics GmbH (OMEICOS) is a biopharmaceutical company that develops small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. The company utilizes its proprietary technology of the body’s own omega-3 fatty acid metabolic processes to …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • Fujikoh Company Ltd-エネルギー分野:企業M&A・提携分析
    Summary Fujikoh Company Ltd (Fujikoh Company) is a clean technology company that offers waste recycling services. The company provides biomass and environmental recycling services. It offers construction waste recycling, waste food recycling and termite dismantling and demolition services. Fujikoh C …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …
  • Stilo International Plc (STL):企業の財務・戦略的SWOT分析
    Summary Stilo International plc (Stilo) operates as a technology company that offers cloud content solutions. The company’s products include developer tools, XML cloud conversion and SME authoring. It offers digital content and publishes information to multiple channels such as print, web, CD-ROM, s …
  • Visioneering Technologies Inc (VTI):企業の製品パイプライン分析2018
    Summary Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. The company develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel ma …
  • Supervalu Inc (SVU):企業の財務・戦略的SWOT分析
    Supervalu Inc (SVU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • E*Trade Financial Corporation:企業のM&A・事業提携・投資動向
    E*Trade Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's E*Trade Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Jadason Enterprises Limited (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Limited (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Australian Agricultural Company Limited:企業の戦略・SWOT・財務分析
    Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆